Recombinant Spider Silk Expression in E. coli
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in producing large quantities of synthetic spider silk with properties similar to natural spider silk, as current methods face issues with low yield and low water solubility due to the small protein size and carnivorous nature of spiders, making large-scale commercial production difficult.
Innovation Solution
A method involving transforming bacterial cells with an expression vector system containing a spider silk protein-encoding open reading frame, a transfer RNA gene, and an antibiotic resistance gene, followed by fermentation and induction to produce and purify synthetic spider silk protein, utilizing a DNA vector system that includes a first antibiotic resistance gene, a spider silk protein-encoding open reading frame, and a transfer RNA gene to enhance expression in E. coli.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If spiders are farmed to produce spider silk, then natural spider silk can be obtained, but large-scale production is difficult due to the carnivorous nature of spiders
Solution Approach 1:
The patent clones the spider silk gene and inserts it into E. coli bacteria, creating a copy of the silk-producing capability in a farmable organism. This allows production of spider silk proteins without actually farming spiders, resolving the contradiction between obtaining natural silk and ease of manufacturing.
Solution Approach 2:
The patent replaces the biological system of spider farming with a bacterial fermentation system. Instead of mechanically farming spiders (which is difficult due to their carnivorous nature), the system uses genetic engineering to substitute spider silk production with E. coli protein expression, enabling scalable production.
2Productivity
If spider silk genes are inserted into organisms to produce synthetic silk, then large-scale production becomes possible, but the yield remains low
Solution Approach 1:
The patent optimizes multiple parameters including using T7 promoter for high-level gene expression, co-transforming with tRNA genes to overcome translation bottlenecks, and implementing induction conditions (IPTG concentration, temperature, time) to maximize protein yield while maintaining scalability.
Solution Approach 2:
The patent introduces tRNA genes as intermediaries to facilitate the translation of spider silk mRNA in E. coli. The tRNA acts as a mediator between the spider silk gene and the bacterial protein synthesis machinery, enabling efficient production and resolving the low yield problem while maintaining scalability.
3Quantity of substance
If spider silk is produced through genetic engineering, then large quantities can be produced, but the protein exhibits low water solubility
Solution Approach 1:
The patent modifies specific local regions of the spider silk protein sequence, particularly the N-terminal and C-terminal domains, to enhance solubility while preserving the core repetitive sequence that provides mechanical strength. This allows the protein to maintain both high production quantity and improved water solubility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in significantly increased expression levels of spider silk proteins, achieving yields of at least 0.5 g/L, overcoming the limitations of low yield and solubility, and enabling the production of high-quality synthetic spider silk.
Implementation Method 1
inducing spider silk protein expression in the cultured E. coli with an inducer
Implementation Method 2
fermenting the transformed bacterial cells in a culture medium
Data Source
AI summary
A method of producing synthetic spider silk, including: transforming Escherichia coli with an expression vector; fermenting the transformed E. coli in a culture medium; inducing spider silk protein expression in the cultured E. coli; extracting the spider silk; and purifying the spider silk. Related vectors and genetically modified cells are also disclosed.